Low neutralizing antibody titers after asymptomatic or non-severe SARS-CoV-2 infection over a 6-month assessment period

Affiliations

• ¹ Occupational health unit, Service of Hospital Preventive Medicine, Lausanne University Hospital, Lausanne, Switzerland.
• ² Frontier Science Foundation-Hellas, Athens, Greece.
• ³ Frontier Science Foundation-Hellas, Athens, Greece; National and Kapodistrian University of Athens, Athens, Greece.
• ⁴ Infectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland; Institute of Microbiology, Lausanne University Hospital and University, Lausanne, Switzerland.
• ⁵ Roche Pharma Research and Early Development, Roche Innovation Center Basel, Basel, Switzerland.
• ⁶ Infectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
• ⁷ Service of Hospital Preventive Medicine, Lausanne University Hospital, University of Lausanne, Lausanne, Switzerland.
• ⁸ Immunology Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland.
• ⁹ Infectious Diseases Service, Department of Medicine, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland. Electronic address: [email protected].